Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

UP: Confusion over man's death, doctor questions whether he actually got COVID jab

Farhat Nasim21 March 2021 9:00 AM IST

Mirzapur: Confusion prevails here over the death of a labourer in his 30s, two days after vaccination, with an official questioning whether he...

MP: Photos of two women at govt hospital mortuary cause stir

Farhat Nasim20 March 2021 9:00 AM IST

Indore: After the photos of two women inside the mortuary of the government-run M Y Hospital here went viral, action was taken against two contractual...

IMA plea against allowing PG Ayurveda doctors to perform surgery: SC seeks Center's response

Farhat Nasim16 March 2021 9:45 AM IST

A bench comprising Chief Justice S A Bobde and Justices A S Bopanna and V Ramasubramanian issued notices to the Ministry of Ayush, CCIM and National...

US-Based Group Sponsors MBBS Studies of 5 Poor Students of Zindagi programme in Odisha

Farhat Nasim16 March 2021 9:00 AM IST

All 19 students of the organisation have successfully qualified for NEET 2020 and many of them have got admission into prestigious medical colleges.

Liberalise regulatory system, particularly for drug approvals: Zydus Group Chairman to Govt

Farhat Nasim26 Feb 2021 7:12 PM IST

Zydus Group Chairman Pankaj R Patel said the pharma industry can grow to USD 80 90 billion in turnover with normal growth rate but with new...

Online CMEs facing tough time with medical council for Credit hours, reveals RTI

Farhat Nasim26 Feb 2021 5:34 PM IST

New Delhi: Despite the growth of the Covid-19 pandemic, online Continuing Medical Education (CME) seems to be finding a tough time getting recognition...

Delhi HC reprimands DCGI after portions of CDSCO drug approval process report found missing

Farhat Nasim22 Feb 2021 6:24 PM IST

The court also directed DCGI to file a status report with regard to the steps taken by it to digitize its records, saying "there is no reason why DCGI...

Zydus Cadila division settles patent litigation with Adamas Pharma over dyskinesia drug Gocovri

Farhat Nasim17 Feb 2021 6:23 PM IST

New Delhi: The US generic drug division of Zydus Cadila Healthcare, Zydus Pharmaceuticals (USA) Inc., and Zydus Worldwide DMCC recently entered into a...

Pfizer-BioNTech to supply European Union with 200 million more Covid-19 shots

Farhat Nasim17 Feb 2021 9:00 AM IST

"We are working relentlessly to support the further roll out of vaccination campaigns in Europe and worldwide by expanding manufacturing capacity,"...

NPPA fixes retail price of Vildagliptin, Metformin Hydrochloride FDCs made by Macleods

Farhat Nasim16 Feb 2021 5:35 PM IST

New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of Fixed-Dose Combination (FDC) of Vildagliptin and...

Torrent Pharma to get NPPA notice for failing to apply for price fixation of FDCs despite expiry of exemption

Farhat Nasim15 Feb 2021 6:11 PM IST

New Delhi: Noting that Torrent Pharmaceuticals Ltd, being an existing manufacturer of formulations including Fixed-Dose Combination (FDC) of Prasugrel...

NPPA takes on Wockhardt over Insulin Human Injection, moves to regulate price

Farhat Nasim14 Feb 2021 10:52 AM IST

New Delhi: Pharma major Wockhardt is soon going to face stringent action from the NPPA over the price of its Insulin Human injections. The...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok